BONE METABOLISM AND EFFECTIVENESS OF ZOLEDRONIC ACID IN LOCALLY ADVANCED AND DISSEMINATED PROSTATE CANCER
- Authors: Glybochko P.V.1, Alyaev Y.G.1, Vinarov A.Z.1, Demidko Y.L.1, Zelenova OV1, Shpot' E.V.1, Glybochko P.1, Alyaev Y.G1, Vinarov AZ1, Demidko Y.L1, Zelenova OV1, Shpot Y.V1
-
Affiliations:
- Issue: No 7 (2011)
- Pages: 37-40
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278858
- ID: 278858
Cite item
Full Text
Abstract
About the authors
Petr Vital'evich Glybochko
Yuriy Gennad'evich Alyaev
Andrey Zinov'evich Vinarov
Yuriy Leonidovich Demidko
O V Zelenova
Evgeniy Valer'evich Shpot'
PV Glybochko
Yu G Alyaev
A Z Vinarov
Yu L Demidko
O V Zelenova
Ye V Shpot
References
- Bruder JM, Ma JZ, Basler JW, et al. Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy. Urology 2006;67(1):152-55.
- Preston DM, Torrens JI, Harding P, et al. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Prostate Cancer Prostatic Dis 2002;5(4):304-10.
- Моисеенко, В.И. Паллиативное лечение больных солидными опухолями с метастатическим поражением костей В. И. Моисеенко. Лекции по фундаментальной и клинической онкологии / Под ред. В.И. Моисеенко, А.Ф. Урманчеевой, К.П. Хансона. СПб., 2004.
- Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995;16(1):87-116.
- Eastham JA. Bone health in men receiving androgen deprivation therapy for prostate cancer. J Urol 2007;177(1):17-24.
- Percival RC, Urwin GH, Harris S, et al. Biochemical and histological evidence that carcinoma of the prostate is associated with increased bone resorption. Eur J Surg Oncol 1987;13(1):41-49.
- Clarke NW, McClure J, George NJ. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol 1991;68(1):74-80.
- Oefelein MG, Ricchiuti V, Conrad W, et al. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 2002;168(3):1005-07.